EMALEX BIOSCIENCES
Live / Registered — Registered (as of 11 Nov 2025)
What this means for you
Registered since 11 Nov 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98417013
- Registration number
- 8024845
- Mark type
- Design + words
- Filed
- 22 Feb 2024
- Published for opposition
- 15 Oct 2024
- Registered
- 11 Nov 2025
- Attorney of record
- Kristen Ruisi
Goods and services
- Class 042 — Scientific and technological services: Research and development of medications and treatment for central nervous system disorders
- Class 044 — Medical, beauty and agricultural services: Providing healthcare and medical information; healthcare services, namely providing information in the field of health, wellness, Tourette Syndrome and other central nervous system disorders; providing website featuring information in the field of central nervous system disorders treatments; providing information, news, and commentary in the field of central nervous system disorders
Owner
- Emalex Biosciences, Inc., Chicago, IL, US
- Emalex Biosciences, Inc., Chicago, IL, US
- Emalex Biosciences, Inc., Chicago, IL, US
Prosecution history
- 11 Nov 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 11 Nov 2025 — REGISTERED-PRINCIPAL REGISTER
- 17 Oct 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 17 Oct 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 14 Oct 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 14 Oct 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 14 Oct 2025 — ASSIGNED TO LIE
- 03 Oct 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 30 Sept 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 30 Sept 2025 — NON-FINAL ACTION E-MAILED
- 30 Sept 2025 — SU - NON-FINAL ACTION - WRITTEN
- 13 Aug 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 26 Nov 2024 — USE AMENDMENT FILED
- 13 Aug 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 26 Nov 2024 — TEAS STATEMENT OF USE RECEIVED